DOJ Actions Suggest Expansion Of Healthcare Enforcement
Recent actions by the U.S. Department of Justice and U.S. Food and Drug Administration suggest a notable shift in federal healthcare enforcement away from traditional program-based fraud and toward cases centered...To view the full article, register now.
Already a subscriber? Click here to view full article